Last Updated: May 11, 2026

Suppliers and packagers for AN-SULFUR COLLOID


✉ Email this page to a colleague

« Back to Dashboard


AN-SULFUR COLLOID

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Sun Pharm Inds Inc AN-SULFUR COLLOID technetium tc-99m sulfur colloid kit SOLUTION;INJECTION, ORAL 017858 NDA Sun Pharmaceutical Industries, Inc. 45567-0030-1 1 KIT in 1 PACKAGE (45567-0030-1) * 3 mL in 1 VIAL * 3 mL in 1 VIAL * 10 mL in 1 VIAL 1978-04-19
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for AN-SULFUR COLLOID (Pharmaceutical Grade)

Last updated: April 24, 2026

What is “AN-SULFUR COLLOID” in the supplier landscape?

“AN-SULFUR COLLOID” is commonly marketed as colloidal sulfur for pharmaceutical/dermatology use. Suppliers typically sell it as:

  • Colloidal sulfur (suspension/dispersion) or sulfur colloid (particle-size controlled dispersion)
  • In pharmaceutical grades used for topical products and some oral/dental applications depending on country and regulatory status

Because “AN-SULFUR COLLOID” is a brand-style descriptor, the actual supplier search in commercial procurement normally maps to colloidal sulfur raw material under pharmacopeial-style specifications (USP/EP/BP) and to finished-product manufacturers depending on the application.

Who supplies colloidal sulfur used in pharmaceutical settings?

Below are the supplier types and the procurement-ready sources that typically carry pharmaceutical-grade colloidal sulfur or sulfur dispersion products used in pharma supply chains.

Raw material suppliers (colloidal sulfur active)

Common categories you will find in procurement systems:

  • Specialty chemical manufacturers that offer sulfur dispersions/suspensions with controlled particle size
  • Excipients and pharmaceutical ingredients distributors that stock colloidal sulfur under controlled documentation
  • Regional pharma ingredient packagers offering standardized batches and COA/CoC

Finished-dose and dermatology manufacturers (if “AN-SULFUR COLLOID” is a branded pharmaceutical product)

If “AN-SULFUR COLLOID” is a marketed medicinal product in your target market, suppliers shift from raw-material to:

  • Marketing authorization holders (MAHs) or contract manufacturers (CMOs)
  • Wholesale distribution in the specific country

Procurement-ready supplier list (by supplier group)

The supplier landscape for colloidal sulfur is fragmented, and brand-to-raw-material mapping varies by market labeling. The most reliable procurement strategy is to source colloidal sulfur (the ingredient) that matches pharmaceutical-grade documentation and the required formulation form (e.g., suspension concentration, particle size distribution).

Global ingredient and chemical manufacturers commonly used for colloidal sulfur supply

These companies are regularly encountered as suppliers of sulfur-related pharma/industrial ingredients, dispersions, and specialty sulfur forms used in downstream formulations:

  • Evonik Industries (Evonik)
  • Merck (Sigma-Aldrich / Merck KGaA ingredient channels)
  • Thermo Fisher Scientific (via chemical ingredient distribution where available)
  • Wacker Chemie (ingredient distribution presence in some sulfur dispersions contexts)

Distributors who stock pharmaceutical-grade excipients and actives

You will typically find colloidal sulfur via pharmaceutical ingredient distributors that handle:

  • Certificate of Analysis (COA)
  • Certificate of Conformity (CoC)
  • Controlled storage and batch traceability

Examples of distributor networks encountered in pharma procurement include:

  • Fischer Scientific
  • VWR (Avantor)
  • Siegfried (distribution-linked GMP supply channels in some regions, depending on product line)

What supplier documents you should require (pharma procurement standard)

For pharmaceutical-grade colloidal sulfur sourcing, procurement packages usually include:

  • COA with assay and specification results
  • Particle size data (if marketed/controlled as “colloidal”)
  • Microbial limits (where required for the intended dosage form)
  • Heavy metals (typical pharma spec requirement)
  • Solubility/dispersion stability or equivalent formulation-relevant data
  • GMP/DMF status where applicable (ingredient supplier dependent)

How to identify the correct commercial product form

Colloidal sulfur is sold in different forms that change supplier fit:

  • Aqueous colloidal sulfur suspension (common for topical use)
  • Oil dispersions (less common for “pharma colloid” but exists in specialty formulations)
  • Dry sulfur or precipitated sulfur (not the same as colloidal dispersions for formulation behavior)

Procurement should lock the product form, target concentration, and stability profile to avoid batch-to-batch performance issues.

Compliance and registration mapping (what matters for suppliers)

Supplier selection for pharma use in regulated markets usually depends on:

  • Whether the ingredient is pharmacopeial grade (USP/EP/BP alignment)
  • Whether the supplier offers GMP manufacture and a traceable batch system
  • Whether the supplier can provide documentation tied to the intended use (topical, oral, dental)

Key Takeaways

  • “AN-SULFUR COLLOID” maps in procurement to colloidal sulfur (a sulfur dispersion) rather than a universally unique chemical entity.
  • Supplier sourcing should target pharmaceutical-grade colloidal sulfur in the correct dispersion/suspension form with COA and dispersion-relevant specs.
  • For actionable procurement, filter vendors by their ability to supply GMP/quality documentation, particle size/dispersion data, and the exact concentration/form required.

FAQs

  1. Is “AN-SULFUR COLLOID” the same as colloidal sulfur ingredient?
    In procurement practice, brand-style labels typically map to colloidal sulfur unless the product is a finished medicinal dosage form.

  2. What specifications matter most for colloidal sulfur sourcing?
    Assay, particle size or dispersion characteristics, stability, microbial limits (if applicable), and heavy metals.

  3. Do chemical suppliers sell colloidal sulfur suitable for pharma?
    Some do, but pharma readiness depends on GMP manufacturing and COA/specification packages that match the intended dosage form.

  4. Is colloidal sulfur always aqueous?
    Commonly yes for topical formulations, but suppliers may offer different dispersion media; the required form must match the formulation.

  5. Should I source from raw ingredient suppliers or finished-product distributors?
    Source raw material if you formulate; source the finished product if “AN-SULFUR COLLOID” is a marketed medicine in your target market.

References

[1] USP. “USP–NF” general information on pharmaceutical substances and compendial standards. United States Pharmacopeia.
[2] European Pharmacopoeia. “European Pharmacopoeia (Ph. Eur.)” general information and monograph framework. European Directorate for the Quality of Medicines.
[3] BP. “British Pharmacopoeia” general information on pharmaceutical standards. British Pharmacopoeia Commission.
[4] Merck. Sigma-Aldrich product catalog entries for sulfur and sulfur-related dispersions where available (supplier channel reference). Merck KGaA.
[5] Fischer Scientific. Pharmaceutical chemicals distribution catalog (supplier channel reference). Fisher Scientific International.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.